{
  "table_index": 26,
  "headers": [
    "Capitalized research and development $ 15,041 $ 10,739"
  ],
  "rows": [
    [
      "Tax credit carryforwards 8,643 8,856"
    ],
    [
      "Accrued liabilities and other reserves 6,154 6,114"
    ],
    [
      "Deferred revenue 2,953 3,413"
    ],
    [
      "Lease liabilities 2,577 2,410"
    ],
    [
      "Other 3,049 3,341"
    ],
    [
      "Total deferred tax assets 38,417 34,873"
    ],
    [
      "Less: Valuation allowance (10,966) (8,866)"
    ],
    [
      "Total deferred tax assets, net 27,451 26,007"
    ],
    [
      "Deferred tax liabilities:"
    ],
    [
      "Depreciation 3,276 2,551"
    ],
    [
      "Right-of-use assets 2,300 2,125"
    ],
    [
      "Minimum tax on foreign earnings 1,217 1,674"
    ],
    [
      "Other 678 455"
    ],
    [
      "Total deferred tax liabilities 7,471 6,805"
    ],
    [
      "Net deferred tax assets $ 19,980 $ 19,202"
    ]
  ],
  "row_count": 15,
  "col_count": 1,
  "page": 44,
  "source": "PDF: _10-K-2025-As-Filed.pdf"
}